Literature DB >> 25903092

[Osteoarthritis: what internists should know].

L Wildi1.   

Abstract

Osteoarthritis is the most frequent joint disorder and substantially affects patient quality of life. As an age-related disease it leads to an increasing financial burden for the healthcare system due to the current demographic changes. Osteoarthritis affects every single tissue in the joint. The identification of the source of disease symptoms is the key to a successful management. Therapeutic approaches include non-pharmacological and pharmacological treatment. Surgery is the therapeutic end stage (e.g. total joint replacement, high tibial osteotomy and arthrodesis). This overview focuses on the pharmacological treatment whereas the clinical manifestations and non-pharmacological approaches are only briefly dealt with.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25903092     DOI: 10.1007/s00108-014-3618-3

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  68 in total

1.  Radiological assessment of osteo-arthrosis.

Authors:  J H KELLGREN; J S LAWRENCE
Journal:  Ann Rheum Dis       Date:  1957-12       Impact factor: 19.103

Review 2.  Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF).

Authors:  David M Dohan Ehrenfest; Lars Rasmusson; Tomas Albrektsson
Journal:  Trends Biotechnol       Date:  2009-01-31       Impact factor: 19.536

Review 3.  Intraarticular platelet-rich plasma injection in the treatment of knee osteoarthritis: review and recommendations.

Authors:  Adam M Pourcho; Jay Smith; Stephen J Wisniewski; Jacob L Sellon
Journal:  Am J Phys Med Rehabil       Date:  2014-11       Impact factor: 2.159

4.  Morphological analysis of articular cartilage biopsies from a randomized, clinical study comparing the effects of 500-730 kDa sodium hyaluronate (Hyalgan) and methylprednisolone acetate on primary osteoarthritis of the knee.

Authors:  D D Guidolin; I P Ronchetti; E Lini; D Guerra; L Frizziero
Journal:  Osteoarthritis Cartilage       Date:  2001-05       Impact factor: 6.576

5.  Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study.

Authors:  Karel Pavelká; Jindriska Gatterová; Marta Olejarová; Stanislav Machacek; Giampaolo Giacovelli; Lucio C Rovati
Journal:  Arch Intern Med       Date:  2002-10-14

6.  Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial.

Authors:  J Y Reginster; R Deroisy; L C Rovati; R L Lee; E Lejeune; O Bruyere; G Giacovelli; Y Henrotin; J E Dacre; C Gossett
Journal:  Lancet       Date:  2001-01-27       Impact factor: 79.321

Review 7.  Primer: managing NSAID-induced ulcer complications--balancing gastrointestinal and cardiovascular risks.

Authors:  Francis K L Chan
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2006-10

8.  Effect of sodium hyaluronate on prevention of osteoarthritis.

Authors:  N H Kim; C D Han; H M Lee; I H Yang
Journal:  Yonsei Med J       Date:  1991-06       Impact factor: 2.759

9.  Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification.

Authors:  Gust Verbruggen; Ruth Wittoek; Bert Vander Cruyssen; Dirk Elewaut
Journal:  Ann Rheum Dis       Date:  2011-11-29       Impact factor: 19.103

10.  Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial.

Authors:  Jean-Yves Reginster; Janusz Badurski; Nicholas Bellamy; William Bensen; Roland Chapurlat; Xavier Chevalier; Claus Christiansen; Harry Genant; Federico Navarro; Evgeny Nasonov; Philip N Sambrook; Timothy D Spector; Cyrus Cooper
Journal:  Ann Rheum Dis       Date:  2012-11-01       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.